| |
|
DCIS |
T1a |
|
| Factors |
Category |
267 cases |
86 cases |
Pvalue
( χ2 test) |
Age (years)
(range) |
|
56.9±13.7
(25～87) |
58.4±12.8
(32~84) |
|
| Menopausal status |
pre |
100 (38%) |
32(37%) |
|
| |
post |
164 |
54 |
|
| Nuclear grade |
3 |
19 (7%) |
13(15%) |
0.001 |
| |
1,2 |
239 |
72 |
|
| ER |
+ |
228 (85%) |
57 (66%) |
0.001 |
| |
- |
37 |
28 |
|
| PgR |
+ |
210 (79%) |
48 (56%) |
<0.0001 |
| |
- |
55 |
37 |
|
| HER2 |
+ |
51(19%) |
32 (37%) |
0.006 |
| |
- |
213 |
54 |
|
| Ki-67 |
+ |
71 (27%) |
39(45%) |
0.002 |
| |
- |
193 |
47 |
|
| p53 overexpression |
+ |
35(13%) |
21(24%) |
0.001 |
| - |
228 |
65 |
|
| Surgery |
Bp |
160 (60%) |
56 (65%) |
0.222 |
| |
Bt |
103 |
28 |
|
| |
Unknown |
4 |
2 |
|
| Adjuvant therapy |
None |
182(68%) |
34 (40%) |
<0.0001 |
| Chemotherapy |
7 |
9 |
|
| |
Endocrine therapy |
72(27%) |
39(45%) |
|
| |
Chemo-endocrine therapy |
3 |
3 |
|
| Recurrence |
with |
3* |
1* |
|
| site |
Ipsilateral breast |
3* |
1* |
|
|
